论文信息 - A cancer gene therapy approach utilizing an anti-erbB-2 single-chain antibody-encoding adenovirus (AD21): a phase I trial. - 字舞流文

A cancer gene therapy approach utilizing an anti-erbB-2 single-chain antibody-encoding adenovirus (AD21): a phase I trial.

Martin R. Johnson | D. Curiel | M. Wang | Minghui Wang | M. Barnes | R. Alvarez | G. Siegal | J. Gómez-Navarro | B. Roberts | M. Johnson | R. Arani | T. Strong | W. Arafat | R. Alvarez